Buscar resultados de ensayos clínicos
Paraneoplastic Syndromes, Nervous System - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condición: Congenital Myasthenic Syndrome Fecha: 2011-11-16 |
No longer available |
Nombre del estudio: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP Condición: Lambert Eaton Myasthenic Syndrome (LEMS) Fecha: 2011-06-20 Intervenciones: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |
Completed |
Nombre del estudio: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) Condición: Lambert Eaton Myasthenic Syndrome Fecha: 2011-06-17 Intervenciones:
|
No longer available |
Nombre del estudio: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome Condición: Lambert-Eaton Myasthenic Syndrome Fecha: 2011-06-13 Intervenciones: Drug: 3,4 DAP Recommended maximum dosage: 20mg four times daily and if needed an additional 20 mg per da |
Completed |
Nombre del estudio: MC-5A for Chemotherapy Induced Peripheral Neuropathy Condición: Neuropathy, Paraneoplastic Fecha: 2010-12-09 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Condición: Congenital Myasthenic Syndrome Fecha: 2010-09-15 Intervenciones: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Available |
Nombre del estudio: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine Condición: Lambert-Eaton Myasthenic Syndrome Fecha: 2009-10-08 Intervenciones: Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses |
Recruiting |
Nombre del estudio: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) Condición:
Fecha: 2009-03-30 Intervenciones:
|
Available |
Nombre del estudio: Treatment of Lambert-Eaton Syndrome With 3,4 DAP Condición: Lambert Eaton Myasthenic Syndrome Fecha: 2008-06-23 Intervenciones: Drug: 3, 4 DAP Patients with clinically-confirmed LEMS will receive 3, 4 DAP by mouth in slowly increasi |
Completed |
Nombre del estudio: Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome Condición: Lambert-Eaton Myasthenic Syndrome Fecha: 2000-02-24 Intervenciones: Drug: 3,4-diaminopyridine |